Virpax Pharmaceuticals

Virpax to Develop Intranasal Cannabidiol Product for the Management of Epilepsy in Adults and Children

BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) has acquired the exclusive worldwide rights from Nanomerics Ltd. to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of …

Virpax to Develop Intranasal Cannabidiol Product for the Management of Epilepsy in Adults and Children Read More